We are live on ! Find out more
SBFMW

Sunshine Biopharma Inc Warrant
SBFMW

1 hedge funds and large institutions have $2.94K invested in Sunshine Biopharma Inc Warrant in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.43% less ownership

Funds ownership: 1.16% → 0.73% (-0.43%)

39% less capital invested

Capital invested by funds: $4.83K → $2.94K (-$1.89K)

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.66K
2
UBS Group
UBS Group
Switzerland
-$213
3
CS
Clear Street
New York
-$14
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$2.94K -$213 -921 -4%
Citadel Advisors
2
Citadel Advisors
Florida
– -$1.66K -12,073 Closed
CS
3
Clear Street
New York
– -$14 -94 Closed

SBFMW Hedge Fund Activity: Q4 2025 in Review

1 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q4 2025, worth a combined $2.94K — down 39% from $4.83K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of SBFMW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, exiting entirely with an estimated $1.66K sold.

  • 1 institutional investor held Sunshine Biopharma Inc Warrant (SBFMW) as of Q4 2025, down from 3 in Q3 2025.
  • Funds reported $2.94K of Sunshine Biopharma Inc Warrant stock for Q4 2025, down 39% quarter-over-quarter.
  • 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q4 2025 and 2 closed out, a net change of -2 holders.
  • The largest Sunshine Biopharma Inc Warrant seller in Q4 2025 was Citadel Advisors, an estimated $1.66K sold.

Based on aggregated 13F filings for Q4 2025.